James Doyle Phd
James is a life sciences entrepreneur passionate about transforming lives through innovation and technological disruption. He has held leadership and executive roles across BioTech, Digital Health, and MedTech startups, including as co-founder and CEO. A scientist by background with a deep understanding of the relation between genetics and disease, James has spent many years building and advancing innovations in the rare disease space and working with non-profits to guide their research programs. Together, his entrepreneurial tenure and scientific background helps him understand the relation between genetics and human health, and how to use this data to impact issues of familial health and inform legacy planning.
James has a BSc in Biochemistry (Hons.) from Concordia University and a PhD in Experimental Medicine from McGill University, both located in his hometown of Montreal, Canada. He served 5 years in the Canadian Armed Forces and currently sits on the Board of Directors of the RQMO, a Rare disease-focused nonprofit."
* James is a resource available to MetaParadigm Wealth Management Clients. He is not affiliated with Metaparadigm, The Strategic Financial Alliance, Inc. or Strategic Blueprint, LLC.